Atrium Therapeutics to Participate in Upcoming Investor Conferences
Atrium Therapeutics (Nasdaq: RNA) will participate in three September investor conferences, with fireside chats at the Wells Fargo 21st Annual Healthcare Conference on September 8 in Boston and the 2026 Cantor Global Healthcare Conference on September 9 in New York. A third appearance is scheduled at the Morgan Stanley 24th Annual Global Healthcare Conference on September 16 in New York, with webcast replays archived on the company's investor relations site for at least 30 days.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.